Not reported
Active02173991Private limited companySutton Coldfield
KAPPA PHARMACEUTICALS LIMITED
Significant control: Uwe Willi Albrecht (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Kappa Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Kappa Pharmaceuticals Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
KAPPA PHARMACEUTICALS LIMITED is an active private limited company (company number 02173991) incorporated on 6 October 1987, registered in Sutton Coldfield. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 December 2024, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
There are 2,418 companies in research and experimental development on biotechnology in the UK with filed accounts; the median reports net assets of £1,000 and is 7 years old.
02
Ownership and control
- Dr Uwe Willi Albrecht
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Ms Erika Albrecht
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 6 October 198739 yrs ago
- Next accounts due
- 30 September 202627 days overdue
- Confirmation statement due
- 20 October 2027in 358 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | — | — | — | £425k | — | — | 0 |
| 31 December 2023 | — | — | — | £425k | — | — | 0 |
Current ratio0.02Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Current assets below creditors within one yearCurrent ratio 0.02
- Incorporated five or more years agoIncorporated 6 October 1987
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 358 days
- Next accounts due27 days overdue
- Accounts period end
- Accounts period end
- Incorporated
08
Similar companies in Birmingham
- CHROMA THERAPEUTICS LIMITEDBirmingham · inc. Sept 2000
- MARLBROOK (UK) LIMITEDBromsgrove · inc. Oct 2000
- EUROFINS SELCIA LIMITEDWolverhampton · inc. Mar 2001
- CELENTYX LIMITEDBirmingham · inc. Dec 2004
- IMMUNEPEPTIDES LIMITEDBirmingham · inc. Aug 2008
- STRIDEZ LIMITEDSutton Coldfield · inc. Jan 2009
All companies incorporated on 6 October 1987 · in Oct 1987.
09
Reminders for KAPPA PHARMACEUTICALS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.